Stage II Prostate Cancer

specific

Stage II includes: IIA: (cT1a-c, cT2a, N0, M0, PSA equal or more than 10 and less than 20, Grade Group 1); (cT2b-c, N0, M0, PSA less than 20, Grade Group 1); IIB: T1-2, N0, M0, PSA less than 20, Grade Group 2; IIC: (T1-2, N0, M0, PSA less than 20, Grade Group 3); (T1-2, N0, M0, PSA less than 20, Grade Group 4). cT1a: Prostate cancer in which the tumor is an incidental histologic finding in 5% or less of tissue resected. cT1b: Prostate cancer in which the tumor is an incidental histologic finding

25

Centers

2

Active Trials

Cancer Funding

Top Centers for Stage II Prostate Cancer(25)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
High-Volume Research Center
73.6
2
NCI Comprehensive
51.1
351.1
4
NCI Comprehensive
51.1
5
NCI Comprehensive
51.1
6
NCI Comprehensive
51.1
751.1
8
NCI Comprehensive
51.1
951.1
10
NCI Comprehensive
51.1
1151.1
1251.1
13
NCI Comprehensive
51.1
14
Rutgers Cancer InstituteNew Brunswick, NJ
NCI Comprehensive
51.1
1551.1
1651.1
1751.1
1851.1
19
Fox Chase Cancer CenterPhiladelphia, PA
NCI Comprehensive
51.1
20
NCI Comprehensive
51.1
2151.1
2251.1
2351.1
2451.1
2551.1

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →